The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter studyXiaochen Fei, Wei Xue, Yiming Gong et al.|Clinical and Translational Medicine|2021Cited by 4
The Comparison of Clinical Utility between Pan-Cancer Panel and Prostate Cancer-Specific Panel for Metastatic Castration Resistant Prostate CancerLiancheng Fan, Wei Xue, Yonghong Li et al.|SSRN Electronic Journal|2021Cited by 0